

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | negative regulation of interleukin-12 production (GO:0032695) | 5.54027910 |
| 2 | positive regulation of gamma-delta T cell activation (GO:0046645) | 5.53048492 |
| 3 | response to peptidoglycan (GO:0032494) | 5.50027143 |
| 4 | negative regulation of cell killing (GO:0031342) | 5.44596747 |
| 5 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 5.44596747 |
| 6 | positive regulation by symbiont of host defense response (GO:0052509) | 5.22516212 |
| 7 | modulation by symbiont of host defense response (GO:0052031) | 5.22516212 |
| 8 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 5.22516212 |
| 9 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 5.22516212 |
| 10 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 5.22516212 |
| 11 | modulation by symbiont of host immune response (GO:0052553) | 5.22516212 |
| 12 | neutrophil activation involved in immune response (GO:0002283) | 5.15436571 |
| 13 | macrophage activation involved in immune response (GO:0002281) | 5.02622562 |
| 14 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 4.59184161 |
| 15 | detection of other organism (GO:0098543) | 4.47865272 |
| 16 | immunoglobulin mediated immune response (GO:0016064) | 4.28013678 |
| 17 | detection of bacterium (GO:0016045) | 4.21876581 |
| 18 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 4.08172465 |
| 19 | antigen processing and presentation of endogenous antigen (GO:0019883) | 4.08072327 |
| 20 | detection of molecule of bacterial origin (GO:0032490) | 4.06147281 |
| 21 | positive regulation of nitric-oxide synthase biosynthetic process (GO:0051770) | 3.99064955 |
| 22 | regulation of interferon-beta biosynthetic process (GO:0045357) | 3.95882426 |
| 23 | regulation of gamma-delta T cell activation (GO:0046643) | 3.91333430 |
| 24 | lipopolysaccharide-mediated signaling pathway (GO:0031663) | 3.90634040 |
| 25 | detection of external biotic stimulus (GO:0098581) | 3.87944292 |
| 26 | cellular response to type I interferon (GO:0071357) | 3.85879786 |
| 27 | type I interferon signaling pathway (GO:0060337) | 3.85879786 |
| 28 | response to type I interferon (GO:0034340) | 3.81674014 |
| 29 | leukocyte aggregation (GO:0070486) | 3.77690614 |
| 30 | granulocyte activation (GO:0036230) | 3.76812316 |
| 31 | neutrophil activation (GO:0042119) | 3.76290153 |
| 32 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 3.73277015 |
| 33 | cellular extravasation (GO:0045123) | 3.69117108 |
| 34 | regulation of dendritic cell antigen processing and presentation (GO:0002604) | 3.64138418 |
| 35 | microglial cell activation (GO:0001774) | 3.62801391 |
| 36 | macrophage activation (GO:0042116) | 3.62235853 |
| 37 | interferon-gamma-mediated signaling pathway (GO:0060333) | 3.59729466 |
| 38 | defense response to protozoan (GO:0042832) | 3.57918358 |
| 39 | myeloid cell activation involved in immune response (GO:0002275) | 3.57885058 |
| 40 | response to host immune response (GO:0052572) | 3.56206647 |
| 41 | response to immune response of other organism involved in symbiotic interaction (GO:0052564) | 3.56206647 |
| 42 | negative regulation of cytokine production involved in immune response (GO:0002719) | 3.54914564 |
| 43 | negative regulation of T cell mediated immunity (GO:0002710) | 3.54380533 |
| 44 | positive regulation of antigen receptor-mediated signaling pathway (GO:0050857) | 3.51535124 |
| 45 | detection of biotic stimulus (GO:0009595) | 3.50031977 |
| 46 | response to muramyl dipeptide (GO:0032495) | 3.49795871 |
| 47 | regulation of interferon-alpha production (GO:0032647) | 3.49700138 |
| 48 | regulation of tumor necrosis factor biosynthetic process (GO:0042534) | 3.49038232 |
| 49 | regulation of mast cell degranulation (GO:0043304) | 3.45894474 |
| 50 | regulation of B cell receptor signaling pathway (GO:0050855) | 3.45587569 |
| 51 | germinal center formation (GO:0002467) | 3.45424247 |
| 52 | respiratory burst (GO:0045730) | 3.43232202 |
| 53 | negative regulation of lymphocyte mediated immunity (GO:0002707) | 3.40655251 |
| 54 | positive regulation of type 2 immune response (GO:0002830) | 3.40200317 |
| 55 | regulation of T-helper 1 cell differentiation (GO:0045625) | 3.37351547 |
| 56 | T-helper 1 type immune response (GO:0042088) | 3.36764384 |
| 57 | response to protozoan (GO:0001562) | 3.32918009 |
| 58 | positive regulation of interleukin-2 biosynthetic process (GO:0045086) | 3.28771474 |
| 59 | positive regulation of interferon-alpha production (GO:0032727) | 3.28027526 |
| 60 | B cell mediated immunity (GO:0019724) | 3.27986940 |
| 61 | regulation of T-helper 2 cell differentiation (GO:0045628) | 3.27750097 |
| 62 | response to defenses of other organism involved in symbiotic interaction (GO:0052173) | 3.22647419 |
| 63 | response to host (GO:0075136) | 3.22647419 |
| 64 | response to host defenses (GO:0052200) | 3.22647419 |
| 65 | positive regulation of antigen processing and presentation (GO:0002579) | 3.22234115 |
| 66 | positive regulation of mast cell activation (GO:0033005) | 3.20508230 |
| 67 | regulation of mast cell activation involved in immune response (GO:0033006) | 3.18237574 |
| 68 | production of molecular mediator involved in inflammatory response (GO:0002532) | 3.16590071 |
| 69 | negative regulation of leukocyte mediated immunity (GO:0002704) | 3.12649106 |
| 70 | negative regulation of erythrocyte differentiation (GO:0045647) | 3.12046735 |
| 71 | regulation of myeloid leukocyte mediated immunity (GO:0002886) | 3.07391422 |
| 72 | regulation of mast cell activation (GO:0033003) | 3.06267863 |
| 73 | regulation of interleukin-12 production (GO:0032655) | 3.04456216 |
| 74 | NIK/NF-kappaB signaling (GO:0038061) | 3.03913357 |
| 75 | regulation of leukocyte degranulation (GO:0043300) | 3.03181713 |
| 76 | T cell migration (GO:0072678) | 3.02961645 |
| 77 | neutrophil mediated immunity (GO:0002446) | 3.02416481 |
| 78 | positive regulation of cellular amide metabolic process (GO:0034250) | 2.99452607 |
| 79 | regulation of type 2 immune response (GO:0002828) | 2.99064832 |
| 80 | positive regulation of interleukin-8 biosynthetic process (GO:0045416) | 2.98967774 |
| 81 | positive regulation of mast cell degranulation (GO:0043306) | 2.94964145 |
| 82 | positive regulation of mast cell activation involved in immune response (GO:0033008) | 2.94964145 |
| 83 | regulation of vitamin D biosynthetic process (GO:0060556) | 2.93086402 |
| 84 | interferon-gamma secretion (GO:0072643) | 2.91211977 |
| 85 | myeloid dendritic cell differentiation (GO:0043011) | 2.89758407 |
| 86 | regulation of interleukin-8 biosynthetic process (GO:0045414) | 2.86813108 |
| 87 | positive regulation of interleukin-1 beta secretion (GO:0050718) | 2.86775847 |
| 88 | negative regulation of innate immune response (GO:0045824) | 2.86551216 |
| 89 | negative regulation of production of molecular mediator of immune response (GO:0002701) | 2.86321768 |
| 90 | regulation of podosome assembly (GO:0071801) | 2.84657870 |
| 91 | regulation of cytokine secretion involved in immune response (GO:0002739) | 2.83491721 |
| 92 | myeloid leukocyte activation (GO:0002274) | 2.83435810 |
| 93 | positive regulation of interferon-beta production (GO:0032728) | 2.82586569 |
| 94 | myeloid dendritic cell activation (GO:0001773) | 2.81818538 |
| 95 | positive regulation of toll-like receptor signaling pathway (GO:0034123) | 2.81767616 |
| 96 | leukocyte migration involved in inflammatory response (GO:0002523) | 2.79654443 |
| 97 | cellular response to interferon-gamma (GO:0071346) | 2.77890183 |
| 98 | negative regulation of interleukin-6 production (GO:0032715) | 2.75490052 |
| 99 | regulation of nitric-oxide synthase biosynthetic process (GO:0051769) | 2.73896282 |
| 100 | positive regulation of NF-kappaB import into nucleus (GO:0042346) | 2.73823573 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 6.06754522 |
| 2 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 5.06289476 |
| 3 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 4.96583592 |
| 4 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 3.68815118 |
| 5 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 3.54981232 |
| 6 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 3.44139527 |
| 7 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 3.44008031 |
| 8 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 3.43748253 |
| 9 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 3.16297938 |
| 10 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 3.14937293 |
| 11 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 3.08447738 |
| 12 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 2.87109304 |
| 13 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 2.84561299 |
| 14 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 2.76434252 |
| 15 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 2.65135957 |
| 16 | VDR_24763502_ChIP-Seq_THP-1_Human | 2.52405987 |
| 17 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 2.51159830 |
| 18 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 2.49349244 |
| 19 | SPI1_23547873_ChIP-Seq_NB4_Human | 2.48077444 |
| 20 | VDR_21846776_ChIP-Seq_THP-1_Human | 2.47200109 |
| 21 | SPI1_23127762_ChIP-Seq_K562_Human | 2.44817593 |
| 22 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 2.41890955 |
| 23 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 2.40540412 |
| 24 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 2.31493538 |
| 25 | RUNX_20019798_ChIP-Seq_JUKART_Human | 2.24768317 |
| 26 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 2.15534503 |
| 27 | SCL_19346495_ChIP-Seq_HPC-7_Human | 2.05356723 |
| 28 | MAF_26560356_Chip-Seq_TH1_Human | 2.04280882 |
| 29 | VDR_24787735_ChIP-Seq_THP-1_Human | 2.02448716 |
| 30 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 2.00563855 |
| 31 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.99191941 |
| 32 | * E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.96975855 |
| 33 | MYB_26560356_Chip-Seq_TH2_Human | 1.93888610 |
| 34 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 1.92370993 |
| 35 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 1.82917606 |
| 36 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 1.80869028 |
| 37 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 1.76901610 |
| 38 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.76475461 |
| 39 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.70743081 |
| 40 | UTX_26944678_Chip-Seq_JUKART_Human | 1.70609287 |
| 41 | MYC_22102868_ChIP-Seq_BL_Human | 1.64494254 |
| 42 | TCF7_22412390_ChIP-Seq_EML_Mouse | 1.62891060 |
| 43 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 1.61507335 |
| 44 | MYB_26560356_Chip-Seq_TH1_Human | 1.60874027 |
| 45 | PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.58448645 |
| 46 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 1.55718285 |
| 47 | KDM2B_26808549_Chip-Seq_DND41_Human | 1.50786045 |
| 48 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.50036731 |
| 49 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.44457595 |
| 50 | MAF_26560356_Chip-Seq_TH2_Human | 1.44316501 |
| 51 | PU_27001747_Chip-Seq_BMDM_Mouse | 1.44190951 |
| 52 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 1.42225797 |
| 53 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.42011255 |
| 54 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 1.40091365 |
| 55 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 1.38074447 |
| 56 | GATA1_22025678_ChIP-Seq_K562_Human | 1.36681900 |
| 57 | GATA3_27048872_Chip-Seq_THYMUS_Human | 1.34714625 |
| 58 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 1.33328280 |
| 59 | CEBPA_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.32722502 |
| 60 | PU.1_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.32671726 |
| 61 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 1.32513717 |
| 62 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.32350555 |
| 63 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.32032663 |
| 64 | CEBPB_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.31440393 |
| 65 | PPARG_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.31423353 |
| 66 | SPI1_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.30715375 |
| 67 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 1.29543235 |
| 68 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 1.26771249 |
| 69 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 1.23126585 |
| 70 | LXR_22292898_ChIP-Seq_THP-1_Human | 1.22549927 |
| 71 | KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 1.22060034 |
| 72 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 1.20607152 |
| 73 | NFE2L2_22581777_ChIP-Seq_LYMPHOBLASTOID_Human | 1.18059913 |
| 74 | GATA3_26560356_Chip-Seq_TH2_Human | 1.15351621 |
| 75 | GATA1_19941826_ChIP-Seq_K562_Human | 1.14647489 |
| 76 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.11167721 |
| 77 | GATA2_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.10416132 |
| 78 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 1.08684385 |
| 79 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.05591616 |
| 80 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 1.03584546 |
| 81 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 1.02515258 |
| 82 | * VDR_20736230_ChIP-Seq_LYMPHOBLASTOID_Human | 1.00861342 |
| 83 | PU.1_20513432_ChIP-Seq_Bcells_Mouse | 1.00381983 |
| 84 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 0.99986115 |
| 85 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 0.98526134 |
| 86 | GATA1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.95887244 |
| 87 | KDM2B_26808549_Chip-Seq_JURKAT_Human | 0.94656368 |
| 88 | SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 0.92995790 |
| 89 | * BCL6_27268052_Chip-Seq_Bcells_Human | 0.92576708 |
| 90 | * BCOR_27268052_Chip-Seq_Bcells_Human | 0.88091818 |
| 91 | GATA2_19941826_ChIP-Seq_K562_Human | 0.81576555 |
| 92 | NCOR1_26117541_ChIP-Seq_K562_Human | 0.78541486 |
| 93 | * STAT1_20625510_ChIP-Seq_HELA_Human | 0.76047839 |
| 94 | TFEB_21752829_ChIP-Seq_HELA_Human | 0.74207536 |
| 95 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 0.73484089 |
| 96 | GATA1_19941827_ChIP-Seq_MEL86_Mouse | 0.73107007 |
| 97 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 0.72132178 |
| 98 | CTCF_27219007_Chip-Seq_ERYTHROID_Human | 0.71240117 |
| 99 | RUNX1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.71134855 |
| 100 | CTNNB1_24651522_ChIP-Seq_LGR5+_INTESTINAL_STEM_Human | 0.70899191 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0003303_peritoneal_inflammation | 4.97090307 |
| 2 | MP0003724_increased_susceptibility_to | 4.55428179 |
| 3 | MP0003436_decreased_susceptibility_to | 4.02536597 |
| 4 | MP0001835_abnormal_antigen_presentation | 3.73819424 |
| 5 | MP0006082_CNS_inflammation | 3.39022395 |
| 6 | MP0009785_altered_susceptibility_to | 3.32837147 |
| 7 | MP0002148_abnormal_hypersensitivity_rea | 3.06098597 |
| 8 | MP0002419_abnormal_innate_immunity | 3.06044911 |
| 9 | MP0005000_abnormal_immune_tolerance | 2.93617429 |
| 10 | MP0005671_abnormal_response_to | 2.93126779 |
| 11 | MP0005387_immune_system_phenotype | 2.88594455 |
| 12 | MP0001790_abnormal_immune_system | 2.88594455 |
| 13 | MP0005025_abnormal_response_to | 2.87700809 |
| 14 | MP0001800_abnormal_humoral_immune | 2.62972204 |
| 15 | MP0003300_gastrointestinal_ulcer | 2.62302595 |
| 16 | MP0002723_abnormal_immune_serum | 2.49061250 |
| 17 | MP0000685_abnormal_immune_system | 2.46835591 |
| 18 | MP0002452_abnormal_antigen_presenting | 2.46591135 |
| 19 | MP0005058_abnormal_lysosome_morphology | 2.36429896 |
| 20 | MP0004510_myositis | 2.35634739 |
| 21 | MP0001533_abnormal_skeleton_physiology | 2.24437161 |
| 22 | MP0002420_abnormal_adaptive_immunity | 2.23876603 |
| 23 | MP0001819_abnormal_immune_cell | 2.23295372 |
| 24 | MP0009764_decreased_sensitivity_to | 2.04566954 |
| 25 | MP0003172_abnormal_lysosome_physiology | 2.02294579 |
| 26 | MP0009278_abnormal_bone_marrow | 1.98312909 |
| 27 | MP0004947_skin_inflammation | 1.88110042 |
| 28 | MP0002405_respiratory_system_inflammati | 1.87863870 |
| 29 | MP0003075_altered_response_to | 1.87318591 |
| 30 | MP0001845_abnormal_inflammatory_respons | 1.86264408 |
| 31 | MP0010155_abnormal_intestine_physiology | 1.85263495 |
| 32 | MP0003191_abnormal_cellular_cholesterol | 1.78615848 |
| 33 | MP0005451_abnormal_body_composition | 1.75984616 |
| 34 | MP0005464_abnormal_platelet_physiology | 1.75684768 |
| 35 | MP0008469_abnormal_protein_level | 1.64769579 |
| 36 | MP0000716_abnormal_immune_system | 1.62659317 |
| 37 | MP0000343_altered_response_to | 1.57946878 |
| 38 | MP0008260_abnormal_autophagy | 1.54176201 |
| 39 | MP0002398_abnormal_bone_marrow | 1.51458989 |
| 40 | MP0009333_abnormal_splenocyte_physiolog | 1.50649160 |
| 41 | MP0008004_abnormal_stomach_pH | 1.49958268 |
| 42 | MP0005397_hematopoietic_system_phenotyp | 1.49284412 |
| 43 | MP0001545_abnormal_hematopoietic_system | 1.49284412 |
| 44 | MP0005310_abnormal_salivary_gland | 1.46854997 |
| 45 | MP0002998_abnormal_bone_remodeling | 1.45076906 |
| 46 | MP0003690_abnormal_glial_cell | 1.44271912 |
| 47 | MP0001853_heart_inflammation | 1.41778585 |
| 48 | MP0003763_abnormal_thymus_physiology | 1.41047616 |
| 49 | MP0003828_pulmonary_edema | 1.39833187 |
| 50 | MP0000858_altered_metastatic_potential | 1.39350342 |
| 51 | MP0009840_abnormal_foam_cell | 1.34260929 |
| 52 | MP0003448_altered_tumor_morphology | 1.31149636 |
| 53 | MP0005166_decreased_susceptibility_to | 1.28735781 |
| 54 | MP0000689_abnormal_spleen_morphology | 1.28309353 |
| 55 | MP0002429_abnormal_blood_cell | 1.25363558 |
| 56 | MP0003806_abnormal_nucleotide_metabolis | 1.25248993 |
| 57 | MP0000604_amyloidosis | 1.24201139 |
| 58 | MP0002722_abnormal_immune_system | 1.23824638 |
| 59 | MP0005167_abnormal_blood-brain_barrier | 1.15650576 |
| 60 | MP0004883_abnormal_blood_vessel | 1.14329547 |
| 61 | MP0003183_abnormal_peptide_metabolism | 1.11739408 |
| 62 | MP0005164_abnormal_response_to | 1.10672312 |
| 63 | MP0000465_gastrointestinal_hemorrhage | 1.09130414 |
| 64 | MP0002332_abnormal_exercise_endurance | 1.08844406 |
| 65 | MP0002132_abnormal_respiratory_system | 1.01908810 |
| 66 | MP0003656_abnormal_erythrocyte_physiolo | 1.01384456 |
| 67 | MP0002277_abnormal_respiratory_mucosa | 1.01144424 |
| 68 | MP0006054_spinal_hemorrhage | 1.00660724 |
| 69 | MP0001851_eye_inflammation | 0.98699218 |
| 70 | MP0009763_increased_sensitivity_to | 0.96783725 |
| 71 | MP0003453_abnormal_keratinocyte_physiol | 0.96418413 |
| 72 | MP0002254_reproductive_system_inflammat | 0.95349186 |
| 73 | MP0003866_abnormal_defecation | 0.94796015 |
| 74 | MP0005390_skeleton_phenotype | 0.91615587 |
| 75 | MP0001663_abnormal_digestive_system | 0.90347290 |
| 76 | MP0000703_abnormal_thymus_morphology | 0.86545153 |
| 77 | MP0002139_abnormal_hepatobiliary_system | 0.81570668 |
| 78 | MP0009765_abnormal_xenobiotic_induced | 0.80762926 |
| 79 | MP0002138_abnormal_hepatobiliary_system | 0.78036545 |
| 80 | MP0004808_abnormal_hematopoietic_stem | 0.72180106 |
| 81 | MP0003091_abnormal_cell_migration | 0.71249990 |
| 82 | MP0002933_joint_inflammation | 0.70894000 |
| 83 | MP0001873_stomach_inflammation | 0.70000760 |
| 84 | MP0000920_abnormal_myelination | 0.69814350 |
| 85 | MP0008874_decreased_physiological_sensi | 0.68709625 |
| 86 | MP0003795_abnormal_bone_structure | 0.67819633 |
| 87 | MP0000249_abnormal_blood_vessel | 0.63190222 |
| 88 | MP0001542_abnormal_bone_strength | 0.60607329 |
| 89 | MP0000490_abnormal_crypts_of | 0.56824434 |
| 90 | MP0003045_fibrosis | 0.55689666 |
| 91 | MP0003221_abnormal_cardiomyocyte_apopto | 0.55031248 |
| 92 | MP0005076_abnormal_cell_differentiation | 0.54509619 |
| 93 | MP0005319_abnormal_enzyme/_coenzyme | 0.54309257 |
| 94 | MP0003195_calcinosis | 0.54282378 |
| 95 | MP0005535_abnormal_body_temperature | 0.52978090 |
| 96 | MP0004381_abnormal_hair_follicle | 0.51660169 |
| 97 | MP0005381_digestive/alimentary_phenotyp | 0.49995090 |
| 98 | MP0002166_altered_tumor_susceptibility | 0.49668085 |
| 99 | MP0002693_abnormal_pancreas_physiology | 0.47328329 |
| 100 | MP0002006_tumorigenesis | 0.47151614 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Eczematoid dermatitis (HP:0000976) | 5.95900445 |
| 2 | Recurrent bacterial skin infections (HP:0005406) | 5.85526219 |
| 3 | Recurrent abscess formation (HP:0002722) | 5.72701900 |
| 4 | Abnormality of macrophages (HP:0004311) | 5.71507879 |
| 5 | Orchitis (HP:0100796) | 5.71273112 |
| 6 | Myositis (HP:0100614) | 5.65063731 |
| 7 | Optic neuritis (HP:0100653) | 5.60069542 |
| 8 | Retrobulbar optic neuritis (HP:0100654) | 5.60069542 |
| 9 | Stomatitis (HP:0010280) | 4.99413645 |
| 10 | Recurrent gram-negative bacterial infections (HP:0005420) | 4.66496616 |
| 11 | Abnormality of glycolipid metabolism (HP:0010969) | 4.45676640 |
| 12 | Abnormality of liposaccharide metabolism (HP:0010968) | 4.45676640 |
| 13 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 4.45676640 |
| 14 | Elevated erythrocyte sedimentation rate (HP:0003565) | 4.19527279 |
| 15 | Mediastinal lymphadenopathy (HP:0100721) | 4.16566758 |
| 16 | Keratoconjunctivitis sicca (HP:0001097) | 3.95590015 |
| 17 | Recurrent fungal infections (HP:0002841) | 3.64688111 |
| 18 | Keratoconjunctivitis (HP:0001096) | 3.63498394 |
| 19 | Recurrent skin infections (HP:0001581) | 3.62070862 |
| 20 | Chronic obstructive pulmonary disease (HP:0006510) | 3.60023978 |
| 21 | Obstructive lung disease (HP:0006536) | 3.60023978 |
| 22 | Increased cerebral lipofuscin (HP:0011813) | 3.56171029 |
| 23 | Gastrointestinal infarctions (HP:0005244) | 3.55050413 |
| 24 | Vasculitis (HP:0002633) | 3.40233560 |
| 25 | Meningitis (HP:0001287) | 3.39311534 |
| 26 | Loss of speech (HP:0002371) | 3.33979837 |
| 27 | Encephalitis (HP:0002383) | 3.29097922 |
| 28 | Systemic lupus erythematosus (HP:0002725) | 3.20530263 |
| 29 | Pulmonary infiltrates (HP:0002113) | 3.19680901 |
| 30 | Amyloidosis (HP:0011034) | 3.17654920 |
| 31 | Gingivitis (HP:0000230) | 3.15817139 |
| 32 | Hemoptysis (HP:0002105) | 3.14709904 |
| 33 | Disinhibition (HP:0000734) | 3.12010818 |
| 34 | Spontaneous hematomas (HP:0007420) | 3.08506415 |
| 35 | Dysostosis multiplex (HP:0000943) | 3.04047737 |
| 36 | Increased IgE level (HP:0003212) | 3.02333596 |
| 37 | Urticaria (HP:0001025) | 3.02197691 |
| 38 | Vacuolated lymphocytes (HP:0001922) | 2.95716534 |
| 39 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 2.89373440 |
| 40 | Recurrent cutaneous fungal infections (HP:0011370) | 2.89162171 |
| 41 | Chronic mucocutaneous candidiasis (HP:0002728) | 2.89162171 |
| 42 | Increased IgM level (HP:0003496) | 2.84373740 |
| 43 | Arterial thrombosis (HP:0004420) | 2.83462034 |
| 44 | Recurrent viral infections (HP:0004429) | 2.83160732 |
| 45 | Episodic fever (HP:0001954) | 2.83151826 |
| 46 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 2.80078139 |
| 47 | Autoimmune thrombocytopenia (HP:0001973) | 2.77660877 |
| 48 | T lymphocytopenia (HP:0005403) | 2.76426460 |
| 49 | Gangrene (HP:0100758) | 2.75351940 |
| 50 | Leukocytosis (HP:0001974) | 2.74626995 |
| 51 | Increased serum ferritin (HP:0003281) | 2.67915211 |
| 52 | Anorexia (HP:0002039) | 2.65033699 |
| 53 | Abnormality of T cell number (HP:0011839) | 2.63007435 |
| 54 | Chest pain (HP:0100749) | 2.60741049 |
| 55 | Petechiae (HP:0000967) | 2.57493023 |
| 56 | Prolonged bleeding time (HP:0003010) | 2.55464041 |
| 57 | Purpura (HP:0000979) | 2.55048399 |
| 58 | Pulmonary embolism (HP:0002204) | 2.54721992 |
| 59 | Cellulitis (HP:0100658) | 2.50632676 |
| 60 | Mutism (HP:0002300) | 2.49992402 |
| 61 | Hematochezia (HP:0002573) | 2.43024221 |
| 62 | Gingival bleeding (HP:0000225) | 2.39047906 |
| 63 | Abnormality of the pleura (HP:0002103) | 2.36306185 |
| 64 | Abnormality of polysaccharide metabolism (HP:0011012) | 2.34570475 |
| 65 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 2.34570475 |
| 66 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 2.34570475 |
| 67 | Polyneuropathy (HP:0001271) | 2.32978661 |
| 68 | Peritonitis (HP:0002586) | 2.31114593 |
| 69 | Hypergammaglobulinemia (HP:0010702) | 2.30567503 |
| 70 | Abnormality of iron homeostasis (HP:0011031) | 2.30375864 |
| 71 | Epistaxis (HP:0000421) | 2.29652659 |
| 72 | Inflammation of the large intestine (HP:0002037) | 2.24174025 |
| 73 | Vertigo (HP:0002321) | 2.24014044 |
| 74 | Hepatosplenomegaly (HP:0001433) | 2.18358262 |
| 75 | Urinary glycosaminoglycan excretion (HP:0003541) | 2.16449266 |
| 76 | Mucopolysacchariduria (HP:0008155) | 2.16449266 |
| 77 | Gastrointestinal inflammation (HP:0004386) | 2.12958396 |
| 78 | Pustule (HP:0200039) | 2.12187653 |
| 79 | Glomerulopathy (HP:0100820) | 2.11370711 |
| 80 | Abnormality of the endocardium (HP:0004306) | 2.10561646 |
| 81 | Acne (HP:0001061) | 2.10079710 |
| 82 | Colitis (HP:0002583) | 2.09847741 |
| 83 | Primitive reflexes (palmomental, snout, glabellar) (HP:0002476) | 2.09392158 |
| 84 | Interstitial pulmonary disease (HP:0006530) | 2.05818780 |
| 85 | Osteomyelitis (HP:0002754) | 2.05452174 |
| 86 | Granulocytopenia (HP:0001913) | 2.04218042 |
| 87 | Malnutrition (HP:0004395) | 2.03568535 |
| 88 | Abnormality of the pericardium (HP:0001697) | 2.00709166 |
| 89 | Abnormality of T cells (HP:0002843) | 2.00061882 |
| 90 | Sepsis (HP:0100806) | 1.98882040 |
| 91 | Keratitis (HP:0000491) | 1.97941072 |
| 92 | Neuronal loss in central nervous system (HP:0002529) | 1.97772703 |
| 93 | Progressive neurologic deterioration (HP:0002344) | 1.97750767 |
| 94 | Glomerulonephritis (HP:0000099) | 1.93298543 |
| 95 | Memory impairment (HP:0002354) | 1.92653006 |
| 96 | Autoimmune hemolytic anemia (HP:0001890) | 1.91489846 |
| 97 | Premature loss of primary teeth (HP:0006323) | 1.91171069 |
| 98 | Intracellular accumulation of autofluorescent lipopigment storage material (HP:0003204) | 1.90431094 |
| 99 | Arthralgia (HP:0002829) | 1.89814148 |
| 100 | Lymphopenia (HP:0001888) | 1.89552783 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | RIPK4 | 4.44158981 |
| 2 | BLK | 3.38340447 |
| 3 | MAP4K1 | 3.13628819 |
| 4 | TYK2 | 3.07827956 |
| 5 | IRAK4 | 3.02778934 |
| 6 | CSK | 2.74832631 |
| 7 | MAP3K14 | 2.62014675 |
| 8 | IRAK3 | 2.60592855 |
| 9 | MAP2K3 | 2.50649506 |
| 10 | PRPF4B | 2.43711478 |
| 11 | ERN1 | 2.38679098 |
| 12 | FGR | 2.26236753 |
| 13 | TBK1 | 2.10971658 |
| 14 | MATK | 2.03242637 |
| 15 | TAOK1 | 2.00434857 |
| 16 | JAK3 | 1.99387513 |
| 17 | IKBKE | 1.98647561 |
| 18 | FES | 1.98067356 |
| 19 | TXK | 1.94698906 |
| 20 | GRK7 | 1.94080621 |
| 21 | MAP3K3 | 1.91619127 |
| 22 | ZAP70 | 1.90945275 |
| 23 | MAP3K11 | 1.85097809 |
| 24 | TAOK2 | 1.73125929 |
| 25 | TNK2 | 1.65428642 |
| 26 | MAP3K13 | 1.60985844 |
| 27 | SYK | 1.54644193 |
| 28 | IKBKB | 1.54578132 |
| 29 | JAK1 | 1.47768794 |
| 30 | BTK | 1.41346848 |
| 31 | HCK | 1.40726696 |
| 32 | BMPR2 | 1.39324111 |
| 33 | EPHB1 | 1.38194200 |
| 34 | LYN | 1.37545092 |
| 35 | JAK2 | 1.35467378 |
| 36 | TGFBR2 | 1.33864160 |
| 37 | CSF1R | 1.28567649 |
| 38 | MAP3K1 | 1.28233311 |
| 39 | SIK3 | 1.24078002 |
| 40 | GRK6 | 1.21039215 |
| 41 | IRAK1 | 1.16176882 |
| 42 | CDC42BPA | 1.13343835 |
| 43 | IRAK2 | 1.12727804 |
| 44 | LCK | 1.08673146 |
| 45 | NME2 | 1.07372973 |
| 46 | KIT | 1.07010506 |
| 47 | DDR2 | 1.05909566 |
| 48 | RIPK1 | 1.03075720 |
| 49 | MOS | 1.02516408 |
| 50 | MARK3 | 1.00804411 |
| 51 | TAOK3 | 1.00680028 |
| 52 | KSR2 | 0.89762312 |
| 53 | STK10 | 0.87354030 |
| 54 | YES1 | 0.75001833 |
| 55 | MAP3K5 | 0.73308357 |
| 56 | MARK2 | 0.72417040 |
| 57 | PDK1 | 0.71832049 |
| 58 | ITK | 0.69763568 |
| 59 | CHUK | 0.68540054 |
| 60 | SIK2 | 0.65925499 |
| 61 | PDPK1 | 0.64357389 |
| 62 | TEC | 0.63486078 |
| 63 | TESK2 | 0.61237577 |
| 64 | MAPK7 | 0.59456482 |
| 65 | PRKD2 | 0.55557375 |
| 66 | EPHA3 | 0.55535160 |
| 67 | FYN | 0.53881028 |
| 68 | DAPK2 | 0.51881320 |
| 69 | HIPK2 | 0.50858934 |
| 70 | FGFR4 | 0.49950735 |
| 71 | PIM1 | 0.49558070 |
| 72 | TRIB3 | 0.47925215 |
| 73 | ADRBK2 | 0.47869861 |
| 74 | CAMKK2 | 0.45461309 |
| 75 | MAP2K6 | 0.45401874 |
| 76 | PTK6 | 0.44405099 |
| 77 | RPS6KC1 | 0.42019138 |
| 78 | RPS6KL1 | 0.42019138 |
| 79 | FGFR3 | 0.41219956 |
| 80 | SIK1 | 0.40894127 |
| 81 | MAP3K6 | 0.40882638 |
| 82 | DYRK1B | 0.40803270 |
| 83 | MAPK12 | 0.40166323 |
| 84 | ACVR1B | 0.39184701 |
| 85 | TYRO3 | 0.36616690 |
| 86 | DYRK3 | 0.35158837 |
| 87 | RPS6KA6 | 0.33934527 |
| 88 | PRKCQ | 0.32483209 |
| 89 | PIM2 | 0.31529842 |
| 90 | CDK6 | 0.31269765 |
| 91 | SGK3 | 0.31225094 |
| 92 | KSR1 | 0.31114980 |
| 93 | MAPK4 | 0.30307578 |
| 94 | ABL1 | 0.30085214 |
| 95 | LRRK2 | 0.29214843 |
| 96 | MAPKAPK2 | 0.27438324 |
| 97 | BMX | 0.26671090 |
| 98 | PRKCD | 0.25174401 |
| 99 | STK11 | 0.24625574 |
| 100 | CLK1 | 0.23104216 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Leishmaniasis_Homo sapiens_hsa05140 | 3.01092035 |
| 2 | * Osteoclast differentiation_Homo sapiens_hsa04380 | 3.00867829 |
| 3 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 2.93386610 |
| 4 | Allograft rejection_Homo sapiens_hsa05330 | 2.66546667 |
| 5 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 2.60966512 |
| 6 | Graft-versus-host disease_Homo sapiens_hsa05332 | 2.52649909 |
| 7 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 2.28095492 |
| 8 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 2.27489897 |
| 9 | Tuberculosis_Homo sapiens_hsa05152 | 2.24951576 |
| 10 | Malaria_Homo sapiens_hsa05144 | 2.22107543 |
| 11 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 2.10678348 |
| 12 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 2.10590146 |
| 13 | Other glycan degradation_Homo sapiens_hsa00511 | 2.06794199 |
| 14 | Asthma_Homo sapiens_hsa05310 | 2.01807713 |
| 15 | Legionellosis_Homo sapiens_hsa05134 | 1.95152421 |
| 16 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 1.92963703 |
| 17 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 1.92317860 |
| 18 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 1.83477151 |
| 19 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 1.82269925 |
| 20 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 1.82071584 |
| 21 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 1.81556290 |
| 22 | TNF signaling pathway_Homo sapiens_hsa04668 | 1.78421433 |
| 23 | Pertussis_Homo sapiens_hsa05133 | 1.74581023 |
| 24 | Influenza A_Homo sapiens_hsa05164 | 1.71076755 |
| 25 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 1.68818252 |
| 26 | African trypanosomiasis_Homo sapiens_hsa05143 | 1.68392381 |
| 27 | Antigen processing and presentation_Homo sapiens_hsa04612 | 1.64237376 |
| 28 | Toxoplasmosis_Homo sapiens_hsa05145 | 1.64070191 |
| 29 | Measles_Homo sapiens_hsa05162 | 1.62706880 |
| 30 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 1.59170573 |
| 31 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 1.58219308 |
| 32 | Lysosome_Homo sapiens_hsa04142 | 1.57160844 |
| 33 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 1.57027805 |
| 34 | Primary immunodeficiency_Homo sapiens_hsa05340 | 1.52573798 |
| 35 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 1.52144729 |
| 36 | Viral myocarditis_Homo sapiens_hsa05416 | 1.46932805 |
| 37 | Phagosome_Homo sapiens_hsa04145 | 1.42119194 |
| 38 | Herpes simplex infection_Homo sapiens_hsa05168 | 1.40972844 |
| 39 | Salmonella infection_Homo sapiens_hsa05132 | 1.40021120 |
| 40 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 1.37830832 |
| 41 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 1.31449262 |
| 42 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 1.31269056 |
| 43 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 1.30503828 |
| 44 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 1.24717889 |
| 45 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 1.16159391 |
| 46 | Hepatitis C_Homo sapiens_hsa05160 | 1.15192252 |
| 47 | Hepatitis B_Homo sapiens_hsa05161 | 1.12297722 |
| 48 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 1.10092965 |
| 49 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 1.07333081 |
| 50 | Shigellosis_Homo sapiens_hsa05131 | 1.04991483 |
| 51 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.97635750 |
| 52 | Apoptosis_Homo sapiens_hsa04210 | 0.87533039 |
| 53 | Amoebiasis_Homo sapiens_hsa05146 | 0.82397515 |
| 54 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.81098613 |
| 55 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.80526721 |
| 56 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.79171108 |
| 57 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.77918580 |
| 58 | Platelet activation_Homo sapiens_hsa04611 | 0.75894700 |
| 59 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.75370401 |
| 60 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.71804125 |
| 61 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.71394670 |
| 62 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.69093937 |
| 63 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.63814939 |
| 64 | Prion diseases_Homo sapiens_hsa05020 | 0.63103651 |
| 65 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.62757170 |
| 66 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.62459262 |
| 67 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.62458260 |
| 68 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 0.60263499 |
| 69 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.59637977 |
| 70 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.59187114 |
| 71 | Bladder cancer_Homo sapiens_hsa05219 | 0.58635612 |
| 72 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.54580626 |
| 73 | Endocytosis_Homo sapiens_hsa04144 | 0.52135793 |
| 74 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.50573941 |
| 75 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 0.50302888 |
| 76 | Notch signaling pathway_Homo sapiens_hsa04330 | 0.49526966 |
| 77 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.46006386 |
| 78 | HTLV-I infection_Homo sapiens_hsa05166 | 0.45583143 |
| 79 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.45145051 |
| 80 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 0.43821666 |
| 81 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.42866020 |
| 82 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.42802328 |
| 83 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.42428244 |
| 84 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 0.41517834 |
| 85 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.39359271 |
| 86 | Insulin resistance_Homo sapiens_hsa04931 | 0.36362878 |
| 87 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.35189317 |
| 88 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.32710939 |
| 89 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.28901929 |
| 90 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.28484772 |
| 91 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.27826857 |
| 92 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.26697396 |
| 93 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.26386377 |
| 94 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.23919127 |
| 95 | Endometrial cancer_Homo sapiens_hsa05213 | 0.22990297 |
| 96 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.22545354 |
| 97 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.21354278 |
| 98 | Rap1 signaling pathway_Homo sapiens_hsa04015 | 0.20266261 |
| 99 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.19216078 |
| 100 | ErbB signaling pathway_Homo sapiens_hsa04012 | 0.16825727 |

